Q3-osavuosiraportti
11 päivää sitten‧1 t 9 min
3,75 DKK/osake
Viimeisin osinko
3,75 %Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 871 502
Myynti
Määrä
1 794 608
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 43 | - | - | ||
| 2 660 | - | - | ||
| 109 | - | - | ||
| 30 | - | - | ||
| 61 | - | - |
Ylin
314,95VWAP
Alin
307,85VaihtoMäärä
1 605,3 5 165 142
VWAP
Ylin
314,95Alin
307,85VaihtoMäärä
1 605,3 5 165 142
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 4.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Ylimääräinen yhtiökokous | 14.11. | |
| 2025 Q3-osavuosiraportti | 5.11. | |
| 2025 Q2-osavuosiraportti | 7.8. | |
| 2025 Q2-osavuosiraportti | 6.8. | |
| 2025 Q1-osavuosiraportti | 7.5. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·36 min sittenAccording to Tobias Nexø, a “well-known stock analyst,” the Novo Nordisk stock is about to explode in price, after his own hen at home started behaving extremely suspiciously, after he – against ALL common sense – gave it an injection of Wegovy “just to see what would happen”. Tobias says that the hen now “walks around with a kind of leadership attitude,” refuses to lay eggs, demands organic feed, and pecks all other animals in the driveway, as if it has become CEO of the entire farm. He states: “My hen has never behaved like this before. I think Wegovy has given her a kind of… personality. She even tried to steal my pen this morning. That must mean that Novo is on the rise”
·6 t sittenDoctor experiences pressure to prescribe weight-loss injections: - Enormous increase https://www.dagbladet.no/nyheter/stort-press-pa-oss-fastleger/83840143
·2 t sittenthe discount that novo nordisk gives trump is actually around 40 % as there were previously payments to middlemen, that means novo nordisk must approximately sell 67% more at the low prices to reach the same income, so it's not entirely impossible as i see it.
·6 t sittenNovo Nordisk lost a bidding war to Pfizer. The matter was mentioned in the White House when Novo Nordisk CEO, Mike Doustar, was visiting. As of today, our bid is higher, and our message to Pfizer is that if they want to buy the company, then reach into their pockets and bid higher. It's a free market, said Novo Nordisk's Mike Doustar. Metzera produces weight loss medication using the by now well-known active substance GLP-1. However, where patients can inject themselves once a month with Metzera's, the preparation is not yet on pharmacy shelves. In fact, it has not even reached phase 3, which is the last trial phase before a product is launched. Metzera is expected to begin phase 3 trials before the end of 2025. If it is not approved, it will have significant consequences for the company's future. And a competitive advantage for Novo Nordisk.
·1 t sittenWhy this debate about old news??
·9 t sittenBased on a Reddit post (not yet confirmed by Novo): Costco cuts prices on Wegovy/Ozempic from 17.11.25 - $199: Wegovy 0,25 mg / Ozempic 0,25-0,5 mg - $349: Wegovy 1-2,4 mg / Ozempic 1 mg - $499: Ozempic 2 mg No price agreements for Eli Lilly products yet. If this is true, it could really affect sales. (https://www.reddit.com/r/Costco/s/ySvQLW9A0v)·2 t sittenhere we have a link to the last 9 months' financial report for novo nordisk https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916445
·1 päivä sitten · MuokattuWHAT IF THE FUND BUYS SHARES FOR 50 BILLION DKK Then they can buy 160 million shares at a price of 311, corresponding to approx. 3.7% of all shares 1) Novo Fonden buys and RETAINS the shares • The number of shares does not change. • Free float decreases slightly. • EPS is unchanged. • Primarily a signal of confidence. Price effect: Slightly positive, but without mechanical value appreciation 2) The shares are BOUGHT AND CANCELLED • The number of outstanding shares decreases by approx. 3.7%. • EPS increases proportionally. • Remaining shareholders own a larger part of the company. Price effect: Significantly more positive than just buying and holding. In short: Retained shares reduce free float and provide some support to the price. Cancelled shares provide real value appreciation per share Anyway - we can always hope 😀
·3 t sittenAs long as the internal operations are performing so poorly, and prices and sales are so much in turmoil, I am merely a daytrader. And mostly on the short side. Still holding onto AI, chip, and weapons. An expected correction can drag out. But I am aware of the risk.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
11 päivää sitten‧1 t 9 min
3,75 DKK/osake
Viimeisin osinko
3,75 %Tuotto/v
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·36 min sittenAccording to Tobias Nexø, a “well-known stock analyst,” the Novo Nordisk stock is about to explode in price, after his own hen at home started behaving extremely suspiciously, after he – against ALL common sense – gave it an injection of Wegovy “just to see what would happen”. Tobias says that the hen now “walks around with a kind of leadership attitude,” refuses to lay eggs, demands organic feed, and pecks all other animals in the driveway, as if it has become CEO of the entire farm. He states: “My hen has never behaved like this before. I think Wegovy has given her a kind of… personality. She even tried to steal my pen this morning. That must mean that Novo is on the rise”
- ·6 t sittenDoctor experiences pressure to prescribe weight-loss injections: - Enormous increase https://www.dagbladet.no/nyheter/stort-press-pa-oss-fastleger/83840143·2 t sittenthe discount that novo nordisk gives trump is actually around 40 % as there were previously payments to middlemen, that means novo nordisk must approximately sell 67% more at the low prices to reach the same income, so it's not entirely impossible as i see it.
- ·6 t sittenNovo Nordisk lost a bidding war to Pfizer. The matter was mentioned in the White House when Novo Nordisk CEO, Mike Doustar, was visiting. As of today, our bid is higher, and our message to Pfizer is that if they want to buy the company, then reach into their pockets and bid higher. It's a free market, said Novo Nordisk's Mike Doustar. Metzera produces weight loss medication using the by now well-known active substance GLP-1. However, where patients can inject themselves once a month with Metzera's, the preparation is not yet on pharmacy shelves. In fact, it has not even reached phase 3, which is the last trial phase before a product is launched. Metzera is expected to begin phase 3 trials before the end of 2025. If it is not approved, it will have significant consequences for the company's future. And a competitive advantage for Novo Nordisk.·1 t sittenWhy this debate about old news??
- ·9 t sittenBased on a Reddit post (not yet confirmed by Novo): Costco cuts prices on Wegovy/Ozempic from 17.11.25 - $199: Wegovy 0,25 mg / Ozempic 0,25-0,5 mg - $349: Wegovy 1-2,4 mg / Ozempic 1 mg - $499: Ozempic 2 mg No price agreements for Eli Lilly products yet. If this is true, it could really affect sales. (https://www.reddit.com/r/Costco/s/ySvQLW9A0v)·2 t sittenhere we have a link to the last 9 months' financial report for novo nordisk https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916445
- ·1 päivä sitten · MuokattuWHAT IF THE FUND BUYS SHARES FOR 50 BILLION DKK Then they can buy 160 million shares at a price of 311, corresponding to approx. 3.7% of all shares 1) Novo Fonden buys and RETAINS the shares • The number of shares does not change. • Free float decreases slightly. • EPS is unchanged. • Primarily a signal of confidence. Price effect: Slightly positive, but without mechanical value appreciation 2) The shares are BOUGHT AND CANCELLED • The number of outstanding shares decreases by approx. 3.7%. • EPS increases proportionally. • Remaining shareholders own a larger part of the company. Price effect: Significantly more positive than just buying and holding. In short: Retained shares reduce free float and provide some support to the price. Cancelled shares provide real value appreciation per share Anyway - we can always hope 😀·3 t sittenAs long as the internal operations are performing so poorly, and prices and sales are so much in turmoil, I am merely a daytrader. And mostly on the short side. Still holding onto AI, chip, and weapons. An expected correction can drag out. But I am aware of the risk.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 871 502
Myynti
Määrä
1 794 608
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 43 | - | - | ||
| 2 660 | - | - | ||
| 109 | - | - | ||
| 30 | - | - | ||
| 61 | - | - |
Ylin
314,95VWAP
Alin
307,85VaihtoMäärä
1 605,3 5 165 142
VWAP
Ylin
314,95Alin
307,85VaihtoMäärä
1 605,3 5 165 142
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 4.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Ylimääräinen yhtiökokous | 14.11. | |
| 2025 Q3-osavuosiraportti | 5.11. | |
| 2025 Q2-osavuosiraportti | 7.8. | |
| 2025 Q2-osavuosiraportti | 6.8. | |
| 2025 Q1-osavuosiraportti | 7.5. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
11 päivää sitten‧1 t 9 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 4.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Ylimääräinen yhtiökokous | 14.11. | |
| 2025 Q3-osavuosiraportti | 5.11. | |
| 2025 Q2-osavuosiraportti | 7.8. | |
| 2025 Q2-osavuosiraportti | 6.8. | |
| 2025 Q1-osavuosiraportti | 7.5. |
Datan lähde: Millistream, Quartr
3,75 DKK/osake
Viimeisin osinko
3,75 %Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·36 min sittenAccording to Tobias Nexø, a “well-known stock analyst,” the Novo Nordisk stock is about to explode in price, after his own hen at home started behaving extremely suspiciously, after he – against ALL common sense – gave it an injection of Wegovy “just to see what would happen”. Tobias says that the hen now “walks around with a kind of leadership attitude,” refuses to lay eggs, demands organic feed, and pecks all other animals in the driveway, as if it has become CEO of the entire farm. He states: “My hen has never behaved like this before. I think Wegovy has given her a kind of… personality. She even tried to steal my pen this morning. That must mean that Novo is on the rise”
- ·6 t sittenDoctor experiences pressure to prescribe weight-loss injections: - Enormous increase https://www.dagbladet.no/nyheter/stort-press-pa-oss-fastleger/83840143·2 t sittenthe discount that novo nordisk gives trump is actually around 40 % as there were previously payments to middlemen, that means novo nordisk must approximately sell 67% more at the low prices to reach the same income, so it's not entirely impossible as i see it.
- ·6 t sittenNovo Nordisk lost a bidding war to Pfizer. The matter was mentioned in the White House when Novo Nordisk CEO, Mike Doustar, was visiting. As of today, our bid is higher, and our message to Pfizer is that if they want to buy the company, then reach into their pockets and bid higher. It's a free market, said Novo Nordisk's Mike Doustar. Metzera produces weight loss medication using the by now well-known active substance GLP-1. However, where patients can inject themselves once a month with Metzera's, the preparation is not yet on pharmacy shelves. In fact, it has not even reached phase 3, which is the last trial phase before a product is launched. Metzera is expected to begin phase 3 trials before the end of 2025. If it is not approved, it will have significant consequences for the company's future. And a competitive advantage for Novo Nordisk.·1 t sittenWhy this debate about old news??
- ·9 t sittenBased on a Reddit post (not yet confirmed by Novo): Costco cuts prices on Wegovy/Ozempic from 17.11.25 - $199: Wegovy 0,25 mg / Ozempic 0,25-0,5 mg - $349: Wegovy 1-2,4 mg / Ozempic 1 mg - $499: Ozempic 2 mg No price agreements for Eli Lilly products yet. If this is true, it could really affect sales. (https://www.reddit.com/r/Costco/s/ySvQLW9A0v)·2 t sittenhere we have a link to the last 9 months' financial report for novo nordisk https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916445
- ·1 päivä sitten · MuokattuWHAT IF THE FUND BUYS SHARES FOR 50 BILLION DKK Then they can buy 160 million shares at a price of 311, corresponding to approx. 3.7% of all shares 1) Novo Fonden buys and RETAINS the shares • The number of shares does not change. • Free float decreases slightly. • EPS is unchanged. • Primarily a signal of confidence. Price effect: Slightly positive, but without mechanical value appreciation 2) The shares are BOUGHT AND CANCELLED • The number of outstanding shares decreases by approx. 3.7%. • EPS increases proportionally. • Remaining shareholders own a larger part of the company. Price effect: Significantly more positive than just buying and holding. In short: Retained shares reduce free float and provide some support to the price. Cancelled shares provide real value appreciation per share Anyway - we can always hope 😀·3 t sittenAs long as the internal operations are performing so poorly, and prices and sales are so much in turmoil, I am merely a daytrader. And mostly on the short side. Still holding onto AI, chip, and weapons. An expected correction can drag out. But I am aware of the risk.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 871 502
Myynti
Määrä
1 794 608
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 43 | - | - | ||
| 2 660 | - | - | ||
| 109 | - | - | ||
| 30 | - | - | ||
| 61 | - | - |
Ylin
314,95VWAP
Alin
307,85VaihtoMäärä
1 605,3 5 165 142
VWAP
Ylin
314,95Alin
307,85VaihtoMäärä
1 605,3 5 165 142
Välittäjätilasto
Dataa ei löytynyt